Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Plasma cell 1Lymphoid 1Dermatologic 1

Conditions

Melanoma 33Carcinoma, Non-Small-Cell Lung 6Uveal Melanoma 5Skin Neoplasms 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 4Kidney Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Mycosis Fungoides 3Esophageal Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Endometrial Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urticaria Pigmentosa 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Pruritus 1Pancreatic Neoplasms 1

Interventions

pembrolizumab 8Nivolumab 4fludarabine 2Cyclophosphamide 2sonidegib 1obinutuzumab 1methyl 5-aminolevulinate 1lutetium Lu 177 dotatate 1fludarabine phosphate 1durvalumab 1daromun 1cabozantinib 1avelumab 1atezolizumab 1advexin 1Tomography, Optical Coherence 1Therapeutics 1Taxes 1Specimen Handling 1Radiotherapy 1ProMune 1Pemetrexed 1Paclitaxel 1Oncolytic Virotherapy 1Mesna 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Lutetium-177 1Interleukin-2 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Blood Specimen Collection × Dermatologic × Clear all
NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
11 enrolled
DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡